Management of therapy-resistant rheumatoid arthritis
- 31 December 1999
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 13 (4) , 737-752
- https://doi.org/10.1053/berh.1999.0057
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory diseaseClinical and Experimental Immunology, 1997
- CAMPATH-1H IN RHEUMATOID ARTHRITIS—AN INTRAVENOUS DOSE-RANGING STUDYRheumatology, 1996
- SJÖGREN'S SYNDROME REVISITED: AUTOIMMUNE EPITHELITISRheumatology, 1996
- Development and Validation of Response Criteria in Rheumatoid Arthritis: Steps Towards an International Consensus on Prognostic MarkersRheumatology, 1996
- Oral type II collagen treatment in early rheumatoid arthritis. A double‐blind, placebo‐controlled, randomized trialArthritis & Rheumatism, 1996
- A survey of radiation synovectomy in Europe, 1991?1993European Journal of Nuclear Medicine and Molecular Imaging, 1995
- Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1Arthritis & Rheumatism, 1994
- DAB486IL‐2 fusion toxin in refractory rheumatoid arthritisArthritis & Rheumatism, 1993
- The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trialsArthritis & Rheumatism, 1993
- Use of a chimeric monoclonal anti‐CD4 antibody in patients with refractory rheumatoid arthritisArthritis & Rheumatism, 1993